Stockholm’s five top and bottom life science shares in Q1

The shaky start of the year in the stock market was marked by omikron outbreaks and extended restrictions, combined with an increased focus on inflation control from central banks. Few had expected the extent of the invasion in Ukraine, something that also was a major theme for stock markets during the quarter.

Read the full article on biostock.se:

https://www.biostock.se/en/2022/04/stockholms-five-top-and-bottom-life-science-shares-in-q1/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/